Companies/NextCell Pharma AB
Follow

NextCell Pharma AB

Nasdaq First North GM Stockholm (Sweden)

NextCell Pharma is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
www.nextcellpharma.com
Current instruments
Type
Ticker
ISIN
SHARE
NXTCL
SE0009723125
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
NXTCL
SE0009723125
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in NextCell Pharma AB with ticker NXTCL
Status
Active
Currency
SEK
First trading date
13 Jul 2017
Exercise
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
NEXTCL
SE0009723125
Spotlight Stock Market
Sweden (SE)
Details of share in NextCell Pharma AB with ticker NEXTCL
Status
Archived
Currency
SEK
First trading date
13 Jul 2017
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
NXTCL
SE0009723125
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in NextCell Pharma AB with ticker NXTCL
Status
Active
Currency
SEK
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
NEXTCL TO1
SE0009888795
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in NextCell Pharma AB with ticker NEXTCL TO1
Status
Archived
Currency
SEK
Trading period
15 Aug 2018 - 11 Sep 2018
Terms
One (1) warrant of series TO1 entitles the holder to subscribe for one (1) new share for SEK 5.0 during the subscriprion period from August 23, 2018 until September 13, 2018.
Update (23.08.2018): The subscription period of the series TO 1 warrants starts today.
Update (05.09.2018): Reminder to exercise your series TO 1 warrants.
Exercise
Sign in to buy
People
Mathias Svahn
CEO
Anders Essen-Möller
Chairman of the board
Camilla Myhre Sandberg
Board member
Edvard Smith
Board member
Hans-Peter Ekre
Board member
Niclas Löwgren
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Hälsovägen 7
Zip code
141 57
City/district
Huddinge
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
556965-8361
LEI code
549300PBFGB5JYKXGA45
First trade date
13 Jul 2017
Registration date
19 Mar 2014
Short name
NXTCL

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More